Compare Direxion Daily Semiconductor Bull 3X Shares (SOXL) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Direxion Daily Semiconductor Bull 3X Shares vs Stryker Corporation — how do they compare? Direxion Daily Semiconductor Bull 3X Shares trades at $158.63, while Stryker Corporation trades at $319.04 (market cap $122.35B). The key difference: Stryker Corporation pays a 1% dividend while Direxion Daily Semiconductor Bull 3X Shares pays none, and Direxion Daily Semiconductor Bull 3X Shares is trading nearer its 52-week high, Stryker Corporation nearer its low. Which is the better fit depends on your goals.
| SOXL | SYK | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $300.77 | $403.53 |
52-Week Low | $23.99 | $282.58 |
Market Cap | — | $122.35B |
Enterprise Value | — | $134.10B |
Dividend Yield | — | 1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Direxion Daily Semiconductor Bull 3X Shares
SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
